Profile data is unavailable for this security.
About the company
Herbalife Ltd. is a global nutrition company. The Company sells weight management; targeted nutrition; energy, sports and fitness; and other nutrition products to and through a network of independent members (Members). Its products include meal replacements, protein shakes, teas, aloes, high-protein snacks, vitamins and supplements, sports nutrition and outer nutrition products. The Company offers a range of meal replacement products, such as protein shakes, bars and soups. Its snack portfolio includes a variety of sweet, savory and creamy options, such as high protein iced coffee, protein bars, snack shakes, soups, baking mixes and others. Its Herbal Aloe Concentrate is a beverage formulated with aloe vera, which can be mixed with water, tea or protein shake. It has also developed a portfolio of dietary supplements, encompassing solutions for heart health, digestive health, immunity and others. It sells products in 95 markets across the world.
- Revenue in USD (TTM)5.07bn
- Net income in USD137.20m
- Incorporated2002
- Employees9.20k
- LocationHerbalife LtdUgland House, South Church StreetP.O. Box 309GtGRAND CAYMAN 00000Cayman IslandsCYM
- Phone+1 3453 104109600
- Fax+1 3 102587019
- Websitehttps://www.herbalife.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
YSB Inc | 2.34bn | -439.72m | 693.36m | 6.31k | -- | 2.62 | -- | 0.2963 | -25.55 | -25.55 | 47.34 | 3.23 | -- | -- | -- | 2,898,498.00 | -- | -- | -- | -- | 10.26 | -- | -18.89 | -- | 1.01 | -- | 0.1002 | -- | 18.90 | -- | -114.23 | -- | -- | -- |
Uniphar PLC | 2.73bn | 47.96m | 711.46m | 3.26k | 14.84 | 2.00 | 8.25 | 0.2604 | 0.1641 | 0.1641 | 9.35 | 1.22 | 2.13 | 12.64 | 12.71 | 782,667.70 | 3.76 | 4.12 | 6.49 | 7.24 | 15.28 | 13.61 | 1.77 | 1.87 | 0.5634 | 3.22 | 0.5338 | 10.93 | 23.30 | 12.48 | -1.69 | 38.98 | 45.53 | -- |
NanJing Pharmaceutical Co Ltd | 7.37bn | 81.00m | 808.99m | 4.90k | 9.93 | 0.8808 | -- | 0.1098 | 0.4513 | 0.4513 | 41.07 | 5.09 | 1.63 | 8.33 | 3.33 | 10,903,610.00 | 2.22 | 2.32 | 7.44 | 8.94 | 6.04 | 6.41 | 1.36 | 1.30 | 1.13 | 2.91 | 0.6359 | 29.82 | 6.71 | 11.35 | -3.00 | 16.93 | -12.67 | 9.86 |
Selcuk Ecza Deposu Ticaret ve Sanayi AS | 3.28bn | -18.55m | 859.46m | 6.00k | -- | 0.1604 | -- | 0.2621 | -0.9767 | -0.9767 | 172.67 | 282.17 | 2.56 | 11.37 | 13.35 | 17,796,740.00 | -1.45 | 3.05 | -4.61 | 8.13 | 9.75 | 9.37 | -0.5656 | 1.24 | 1.01 | -- | 0.2006 | 27.16 | 14.70 | 48.64 | -64.89 | -10.62 | 23.13 | 20.11 |
Neuca SA | 2.93bn | 37.86m | 963.30m | 5.19k | 26.04 | 3.69 | 13.93 | 0.3293 | 34.25 | 34.25 | 2,647.46 | 241.93 | 2.37 | 7.47 | 7.17 | 2,307,345.00 | 3.30 | 3.58 | 12.27 | 13.31 | 11.19 | 10.33 | 1.39 | 1.43 | 0.5034 | 4.22 | 0.3032 | 34.59 | 5.17 | 8.79 | 6.58 | 8.95 | -3.07 | 14.40 |
DocMorris AG | 1.09bn | -132.05m | 973.01m | 1.45k | -- | 1.60 | -- | 0.8936 | -10.07 | 7.03 | 83.05 | 36.60 | 0.9863 | 11.36 | 10.50 | 667,214.10 | -11.96 | -12.92 | -15.23 | -15.74 | 20.98 | 16.84 | -12.13 | -10.87 | 1.34 | -2.39 | 0.4448 | -- | 4.13 | -4.29 | 31.29 | -- | -2.53 | -- |
Guangxi LiuYao Group Co Ltd | 2.93bn | 122.51m | 1.04bn | 5.58k | 7.69 | 0.9885 | -- | 0.3549 | 2.46 | 2.46 | 58.82 | 19.12 | 1.07 | 6.99 | 1.97 | 3,807,204.00 | 4.80 | 5.06 | 11.73 | 12.21 | 11.56 | 11.85 | 4.47 | 4.40 | 1.30 | 5.26 | 0.5434 | 29.90 | 9.23 | 12.18 | 21.11 | 9.97 | -8.63 | 6.26 |
Herbalife Ltd | 5.07bn | 137.20m | 1.10bn | 9.20k | 8.00 | -- | 4.35 | 0.2161 | 1.37 | 1.37 | 50.57 | -10.39 | 1.90 | 2.25 | 58.67 | 551,586.90 | 5.14 | 11.30 | 8.68 | 18.70 | 76.80 | 78.43 | 2.70 | 6.02 | 0.7667 | 2.98 | 1.76 | 0.00 | -2.73 | 0.688 | -55.74 | -13.67 | 9.95 | -- |
Sigma Healthcare Ltd | 2.26bn | 2.98m | 1.25bn | 156.00 | 293.67 | 2.09 | 56.28 | 0.554 | 0.004 | 0.004 | 3.34 | 0.5544 | 2.68 | 11.37 | 10.52 | -- | 0.4162 | 0.5734 | 0.625 | 0.9762 | 9.17 | 9.52 | 0.1554 | 0.2022 | 1.86 | 1.59 | 0.1354 | 184.52 | -9.16 | -3.46 | 148.98 | -34.19 | -46.55 | -21.93 |
GuangYuYuan Chinese Herbal Medicn Co Ltd | 173.43m | 16.76m | 1.52bn | 1.81k | 90.50 | 7.16 | -- | 8.74 | 0.2484 | 0.2484 | 2.57 | 3.14 | 0.4701 | 0.7661 | 1.99 | 694,836.90 | 4.96 | -2.10 | 7.42 | -3.16 | 71.43 | 69.74 | 10.56 | -6.00 | 1.16 | 12.91 | 0.1569 | -- | 13.56 | -4.53 | 136.03 | -24.78 | -58.35 | -- |
Holder | Shares | % Held |
---|---|---|
The Vanguard Group, Inc.as of 31 Mar 2024 | 9.95m | 9.96% |
The WindAcre Partnership LLCas of 31 Mar 2024 | 9.20m | 9.21% |
Route One Investment Co. LPas of 31 Mar 2024 | 8.63m | 8.63% |
Morgan Stanley & Co. LLCas of 31 Mar 2024 | 6.98m | 6.99% |
BlackRock Fund Advisorsas of 31 Mar 2024 | 6.48m | 6.48% |
Renaissance Technologies LLCas of 31 Mar 2024 | 5.96m | 5.96% |
SSgA Funds Management, Inc.as of 31 Mar 2024 | 5.94m | 5.94% |
UBS Securities LLCas of 31 Mar 2024 | 5.28m | 5.28% |
BMO Asset Management Corp.as of 31 Mar 2024 | 3.27m | 3.27% |
Camber Capital Management LPas of 31 Mar 2024 | 3.00m | 3.00% |